secwatch / observer
8-K filed November 16, 2022, 6:59 PM ET ticker TSPH CIK 0001823593
other material confidence high sentiment negative materiality 0.85

TuSimple Holdings Inc. (TSPH): M&A transaction — Mo Chen gains control of TuSimple with ~59% voting power; interim CEO removed, four directors ousted

TuSimple Holdings Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Ersin Yumer

interim Chief Executive Officer and President
TSPH · TuSimple Holdings Inc.
Effective
2022-11-25
Filed
November 16, 2022, 6:59 PM ET
the Company’s board of directors on November 10, 2022 removed Ersin Yumer as interim Chief Executive Officer and President of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ersin Yumer was removed as interim Chief Executive Officer and President at TuSimple Holdings Inc..

Action
removed
Role
interim Chief Executive Officer and President
Exact text from the filing
the Company’s board of directors on November 10, 2022 removed Ersin Yumer as interim Chief Executive Officer and President of the Company.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

TuSimple Holdings Inc. underwent a change of control involving Mr. Mo Chen for no monetary consideration (closed 2022-11-09).

Action
change of control
Counterparty
Mr. Mo Chen
Consideration
no monetary consideration
Closing
2022-11-09
Exact text from the filing
As a result, under the SEC's rules with respect to the beneficial ownership of securities, Mr. Chen acquired control of the Company as of November 9, 2022.
View on SEC.gov

Browse all m&a transactions →

TuSimple Holdings Inc. filing history →

Source: SEC EDGAR
accession 0001193125-22-286181
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.